Numira Biosciences

About:

Numira Biosciences provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models.

Website: http://www.numirabio.com

Twitter/X: NumiraCRO

Top Investors: Kickstart, Tech Coast Angels, vSpring Capital, Pasadena Angels

Description:

Numira Biosciences, Inc., a contract research organization, provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. It offers Virtual Histology for soft tissue imaging applications, such as atherosclerosis, osteoarthritis, heart defects, pulmonary diseases, developmental biology, and phenotyping; and high-resolution bone imaging tools to analyze and characterize the skeletal anatomy and bones of animal models. The company also provides image processing and visual analytics solutions; AltaViewer visualization software, a visualization tool for use in non-clinical environments to view, manipulate, and export images of small animal datasets for research purposes; and imaging chamber, a multi-modality imaging chamber that facilitates the co-registration of anatomical and functional images by means of sequential multi-modal imaging.

Total Funding Amount:

$5.78M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2005-01-01

Contact Email:

cfernandez(AT)numirabio.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2013-03-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai